Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.79 Analyst target: $11.50 Upside: 203.43%
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
See the full interactive analysis & chart →Informational only — not investment advice.